A study of clinical and laboratory parameters in relation to heart failure
Not Applicable
Completed
- Conditions
- Health Condition 1: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure
- Registration Number
- CTRI/2019/01/017139
- Lead Sponsor
- Kasturba Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 163
Inclusion Criteria
1. A known case of heart failure/Recently diagnosed with heart failure
2. BMI < 35
Exclusion Criteria
1. Chronic Respiratory diseases
2. Spinal deformities
3. Unable/Not willing to bend
4. Acute Coronary Syndrome
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To look if Correlation exists between various clinical(including Bendopnea), biochemical and imaging markers and severity of Heart FailureTimepoint: SEPTEMBER 2019
- Secondary Outcome Measures
Name Time Method To see number of hospitalizations based on severity of heart failureTimepoint: SEPTEMBER 2019
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link bendopnea to pathophysiology in combined systolic and diastolic heart failure (I504)?
How does bendopnea compare to established biomarkers like BNP/NT-proBNP in predicting clinical outcomes for I504 patients?
Can bendopnea serve as a reliable biomarker for stratifying I504 heart failure patients in observational studies?
What adverse event profiles are associated with standard-of-care therapies for I504 heart failure in observational cohorts?
Are there novel therapeutic targets or compounds synergistic with bendopnea monitoring in managing combined systolic-diastolic heart failure?